These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. EUROASPIRE II Study Group. Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143 [Abstract] [Full Text] [Related]
23. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Gudbjörnsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM, Swedish National Diabetes Register (NDR). Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761 [Abstract] [Full Text] [Related]
35. Poor hypertension control in Greek patients with diabetes in rural areas. The VANK study in primary care. Skliros E, Sotiropoulos A, Vasibossis A, Xipnitos C, Chronopoulos I, Razis N, Merkouris P. Rural Remote Health; 2007 Jan; 7(3):583. PubMed ID: 17617008 [Abstract] [Full Text] [Related]
36. [Cost of cardiovascular risk factor prevention in middle-aged French men. The PRIME study]. Marques-Vidal P, Arveiler D, Amouyel P, Ducimetière P, Ferrières J. Rev Epidemiol Sante Publique; 2001 Dec; 49(6):541-9. PubMed ID: 11845103 [Abstract] [Full Text] [Related]
39. Trends in cardiovascular risk factors and their treatment among patients discharged from divisions of internal medicine. The FAPOI-1 and FADOI-2 studies. Di Rosa S, Iori I, Vescovo G, Puddu PE, Lanti M, Menotti A. Ital Heart J; 2003 Jul; 4(7):460-7. PubMed ID: 14558297 [Abstract] [Full Text] [Related]